慢性门体性脑病患者基础动脉血氨水平及口服诱导高氨血症的比较研究，采用新霉素、乳果糖以及新霉素与乳果糖联合治疗。 - Suppr

Suppr

超能文献

Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.

作者信息

Pirotte J, Guffens J M, Devos J

出版信息

Digestion. 1974;10(6):435-44. doi: 10.1159/000197556.

DOI:10.1159/000197556

PMID:4448315

Abstract

摘要

相似文献

Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.

Digestion. 1974;10(6):435-44. doi: 10.1159/000197556.

Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.

N Engl J Med. 1969 Aug 21;281(8):408-12. doi: 10.1056/NEJM196908212810803.

Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

Gastroenterology. 1977 Apr;72(4 Pt 1):573-83.

[Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].

Med Klin. 1978 Jan 13;73(2):63-8.

[Treatment of chronic porto-systemic encephalopathy with lactulose].

Schweiz Med Wochenschr. 1969 Apr 19;99(16):584.

Portal systemic encephalopathy--should lactulose and neomycin be used together.

Br J Clin Pract. 1981 Sep;35(9):323-4.

Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.

Am J Med. 1971 Aug;51(2):148-59. doi: 10.1016/0002-9343(71)90233-6.

[Lactulose in the therapy of porto-systemic encephalopathy].

Minerva Med. 1973 Dec 5;64(87):4596-603.

Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.

Am J Dig Dis. 1978 May;23(5):398-406. doi: 10.1007/BF01072921.

Long-term treatment of portal-systemic encephalopathy with lactulose.

Australas Ann Med. 1969 May;18(2):117-23. doi: 10.1111/imj.1969.18.2.117.

引用本文的文献

Use Of Quantitative Modelling To Elucidate The Roles Of The Liver, Gut, Kidney, And Muscle In Ammonia Homeostasis And How Lactulose And Rifaximin Alter This Homeostasis.

Int J Gen Med. 2019 Oct 14;12:367-380. doi: 10.2147/IJGM.S218405. eCollection 2019.

Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.

Gut. 1997 Jun;40(6):726-30. doi: 10.1136/gut.40.6.726.

Progress in the treatment of chronic portasystemic encephalopathy.

Gut. 1984 Jan;25(1):85-98. doi: 10.1136/gut.25.1.85.

Interactions of lactulose and neomycin.

Drugs. 1972;4(1):4-6. doi: 10.2165/00003495-197204010-00002.

Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy.

Drugs. 1972;4(1):7-48. doi: 10.2165/00003495-197204010-00003.

Pathophysiology and clinical basis of prevention and treatment of complications of chronic liver disease.

Klin Wochenschr. 1991 Feb 6;69(3):112-20. doi: 10.1007/BF01795954.

Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.

Am J Dig Dis. 1978 May;23(5):398-406. doi: 10.1007/BF01072921.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验